TY - JOUR
T1 - Delayed hypersensitivity with ferric carboxymaltose
AU - Sridhara, Surabhi
AU - Rajesh, V.
AU - Prabhu, Ravindra
AU - Saraf, Karan
PY - 2017/11/1
Y1 - 2017/11/1
N2 - Ferric Carboxymaltose (FCM) is widely used in the treatment of anaemia of Chronic Kidney Disease (CKD). The clinicians must be alert of the rare adverse events such as hypersensitivity with subsequent doses of Ferric carboxymaltose. Here, we report a case of a 59-year-old male a known case of CKD, with anaemia and thrombocytopenia. Ferric carboxymaltose was the treatment of choice. There was a hypersensitivity reaction to the second dose whereas, the first dose was well tolerated. This case report indicates the onset of adverse reaction with ferric carboxymaltose with the second dose even though the first dose was well tolerated.
AB - Ferric Carboxymaltose (FCM) is widely used in the treatment of anaemia of Chronic Kidney Disease (CKD). The clinicians must be alert of the rare adverse events such as hypersensitivity with subsequent doses of Ferric carboxymaltose. Here, we report a case of a 59-year-old male a known case of CKD, with anaemia and thrombocytopenia. Ferric carboxymaltose was the treatment of choice. There was a hypersensitivity reaction to the second dose whereas, the first dose was well tolerated. This case report indicates the onset of adverse reaction with ferric carboxymaltose with the second dose even though the first dose was well tolerated.
UR - http://www.scopus.com/inward/record.url?scp=85034631111&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85034631111&partnerID=8YFLogxK
U2 - 10.7860/JCDR/2017/25908.10827
DO - 10.7860/JCDR/2017/25908.10827
M3 - Article
AN - SCOPUS:85034631111
SN - 2249-782X
VL - 11
SP - FD01-FD02
JO - Journal of Clinical and Diagnostic Research
JF - Journal of Clinical and Diagnostic Research
IS - 11
ER -